Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s share price was down 6.4% during trading on Monday . The stock traded as low as GBX 2.91 and last traded at GBX 2.91. Approximately 182,832 shares traded hands during mid-day trading, a decline of 84% from the average daily volume of 1,165,047 shares. The stock had previously closed at GBX 3.11.
Cizzle Biotechnology Stock Down 6.4%
The stock has a market capitalization of £12.37 million, a PE ratio of -17.12 and a beta of 0.07. The firm has a 50 day moving average price of GBX 2.64 and a 200 day moving average price of GBX 1.96.
Cizzle Biotechnology (LON:CIZ – Get Free Report) last issued its quarterly earnings data on Tuesday, May 5th. The company reported GBX (0.17) EPS for the quarter.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Further Reading
- Five stocks we like better than Cizzle Biotechnology
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
